These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 15367860)

  • 1. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
    Dalakas MC
    Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory muscle diseases: a critical review on pathogenesis and therapies.
    Dalakas MC
    Curr Opin Pharmacol; 2010 Jun; 10(3):346-52. PubMed ID: 20409756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on idiopathic inflammatory myopathies.
    Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
    Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymyositis and dermatomyositis.
    Dalakas MC; Hohlfeld R
    Lancet; 2003 Sep; 362(9388):971-82. PubMed ID: 14511932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
    Schmidt J; Rakocevic G; Raju R; Dalakas MC
    Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: An update on inflammatory and autoimmune myopathies.
    Dalakas MC
    Neuropathol Appl Neurobiol; 2011 Apr; 37(3):226-42. PubMed ID: 21155862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ
    Front Neurol Neurosci; 2009; 26():126-146. PubMed ID: 19349710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory myopathies: evaluation and management.
    Greenberg SA
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of inflammatory and autoimmune myopathies.
    Dalakas MC
    Presse Med; 2011 Apr; 40(4 Pt 2):e237-47. PubMed ID: 21411269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis of primary inflammatory myopathies].
    Benveniste O; Squier W; Boyer O; Hilton-Jones D; Herson S
    Presse Med; 2004 Nov; 33(20):1444-50. PubMed ID: 15611679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the immunopathogenesis of inclusion-body myositis: present and future prospects.
    Dalakas MC
    Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):948-58. PubMed ID: 12407303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory, immune, and viral aspects of inclusion-body myositis.
    Dalakas MC
    Neurology; 2006 Jan; 66(2 Suppl 1):S33-8. PubMed ID: 16432143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
    Arahata K; Engel AG
    Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular immunology and genetics of inflammatory muscle diseases.
    Dalakas MC
    Arch Neurol; 1998 Dec; 55(12):1509-12. PubMed ID: 9865793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic inflammatory myopathies.
    Amato AA; Barohn RJ
    Neurol Clin; 1997 Aug; 15(3):615-48. PubMed ID: 9227956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cells in muscle in inclusion body myositis and polymyositis.
    Greenberg SA; Bradshaw EM; Pinkus JL; Pinkus GS; Burleson T; Due B; Bregoli L; O'Connor KC; Amato AA
    Neurology; 2005 Dec; 65(11):1782-7. PubMed ID: 16344523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Three patients with divergent presentations of idiopathic inflammatory myopathy].
    Bronner IM; van der Meulen MF; Linssen WH; Hoogendijk JE; de Visser M
    Ned Tijdschr Geneeskd; 2002 May; 146(18):833-8. PubMed ID: 12038218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of myositis: issues, concerns and future prospects.
    Dalakas MC
    Nat Rev Rheumatol; 2010 Mar; 6(3):129-37. PubMed ID: 20125096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease.
    Dalakas MC
    J Clin Immunol; 1995 Nov; 15(6 Suppl):70S-75S. PubMed ID: 8613495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic targets for idiopathic inflammatory myopathies.
    De Bleecker JL; Creus KK; De Paepe B
    Drug News Perspect; 2006 Nov; 19(9):549-57. PubMed ID: 17220960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.